Metabolic features of the adaptive effect of delta-sleep inducing peptide and piracetam under hyperoxic conditions.

Lysenko AV, Alperovich DV, Uskova NI, Mendzheritsky AM · 1999 · Biochemistry. Biokhimiia 64(6):652-657

Animal / experimentalEnglish abstractSource linked

This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

The combination enhanced reported protection alongside changes in neurotransmitter amino acids, membrane ATPase activity and lipid-peroxidation products.

Population and setting: Rats exposed to hyperbaric oxygen at 0.3 MPa for two hours
Evidence type: Animal / experimental
Preparation: DSIP + piracetam
Source language: eng
Title provenance: Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

Hyperoxia is excess oxygen, not oxygen deprivation. These animal findings do not establish a human diving, sleep or performance regimen.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.

Recorded source-check date: 2026-10-01. This date does not imply a completed systematic review.

Open original source or index record ↗

Cite and trace this record

Original source: Lysenko AV, Alperovich DV, Uskova NI, Mendzheritsky AM. Metabolic features of the adaptive effect of delta-sleep inducing peptide and piracetam under hyperoxic conditions. Biochemistry. Biokhimiia 64(6):652-657 1999.

Molekul research summary: https://molekul.io/research/dsip-10395980. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

DSIP

A peptide first characterized in Swiss sleep research and later studied in Soviet/Russian analogue and stress-adaptation programmes. Ordinary DSIP, modified analogues and piracetam combinations have distinct evidence.

Piracetam

Piracetam, marketed as Nootropil, connects the original nootropic concept with Soviet clinical adoption and later operator, hypoxia and maritime research. Healthy-volunteer experiments, clinical reviews and combination proposals answer different questions.

Editorial policy and evidence standards